As Bristol Myers Squibb Co (BMY) Shares Rose, Wellington Management Group Llp Increased Its Stake

May 17, 2018 - By Lisa Delgado

Bristol-Myers Squibb Company (NYSE:BMY) Corporate LogoBig Money Sentiment decreased to 0.94 in 2017 Q4. It has change of 0.09, from 2017Q3’s 1.03. The ratio worsened due to BMY positioning: 72 sold and 526 reduced. 106 funds bought holdings and 457 increased holdings. Investors holded 1.11 billion in 2017Q3 but now own 1.11 billion shares or 0.48% more. Stewart Patten Commerce Ltd holds 0.23% or 20,781 shs. Jensen Inv Management invested 0.03% of its capital in Bristol-Myers Squibb Company (NYSE:BMY). Point72 Asset Management LP holds 0.03% or 115,000 shs in its capital. 5,035 were reported by Sonata Grp Inc. Spirit Of America Mgmt, a New York-based fund reported 14,000 shs. Cornerstone Cap Mgmt Ltd Liability Com invested in 0.15% or 347,968 shs. Wesbanco Bancorp stated it has 1.88% in Bristol-Myers Squibb Company (NYSE:BMY). Missouri-based Duncker Streett And Communication Incorporated has invested 0.97% in Bristol-Myers Squibb Company (NYSE:BMY). State Treasurer State Of Michigan has 0.36% invested in Bristol-Myers Squibb Company (NYSE:BMY). North Mngmt has invested 0.1% of its capital in Bristol-Myers Squibb Company (NYSE:BMY). Mathes Incorporated reported 4,959 shs. Arcadia Mi holds 0.02% or 1,000 shs in its capital. Albion Grp Inc Ut holds 0.48% or 51,503 shs in its capital. Voya Invest Mngmt Ltd Liability has 0.1% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 763,874 shs. Paragon Limited Liability owns 4,009 shs or 0.08% of their US capital.

BMY registered $163,963 net activity with 2 buys and 1 insider sale since December 12, 2017. Samuels Theodore R. II bought 4,000 shs worth $249,187. $335,172 worth of Bristol-Myers Squibb Company (NYSE:BMY) was sold by Lynch Thomas J. Jr..

In 2017Q4 SEC filling is reported Wellington Management Group Llp’s stake in Bristol Myers Squibb Co (BMY) which was rose by 5762516.82%. The company’s stock popped up 2.38% while Wellington Management Group Llp bought 138.07 million shares. The institutional investor is holding 138.07M shares, compared to the 2,396 from the previous quarter. And the reported value of the major pharmaceuticals company is $8.46B for the 2017Q4. $85.36 billion is Bristol Myers Squibb Co’s market cap. BMY hit $52.21 during the last trading session after $0.09 change.Currently Bristol-Myers Squibb Company is uptrending after 11.37% change in last May 17, 2017. BMY has also 5.42M shares volume. BMY underperformed by 0.18% the S&P500.

A portfolio of $452.59 billion is managed by Wellington Management Group Llp. As it’s published in SEC filling the stake in Ranger Energy Svcs Inc is reduced by 758,224 shares to 419,620 shares. They are valued at $3.87M in 2017Q4. For a total of 3.81 million shares it reduced its holding in Rexford Indl Rlty Inc (NYSE:REXR) by 514,888 shares in the quarter, and has cut its stake in Zillow Group Inc.

For more Bristol-Myers Squibb Company (NYSE:BMY) news posted recently go to: Fool.com, Seekingalpha.com, Seekingalpha.com, Bizjournals.com or Streetinsider.com. The titles are as follows: “Why Bristol-Myers Squibb Stock Crashed in April” posted on May 09, 2018, “Ziopharm, Trump’s Drug Pricing Plan And The Future Of Expensive Drug Development” on May 15, 2018, “Don’t Buy L Brands – Cramer’s Lightning Round (5/15/18)” with a publish date: May 16, 2018, “How Bristol-Myers Squibb’s new Peninsula digs boost its battle to beat cancer” and the last “Bristol-Myers Squibb (BMY) Highlights Breadth of Immuno-Oncology–Based Combination Research and Commitment …” with publication date: May 16, 2018.

Bristol-Myers Squibb Company (NYSE:BMY) Ratings Coverage

Total analysts of 11 have positions in Bristol Myers (NYSE:BMY) as follows: 4 rated it a “Buy”, 0 with “Sell” and 7 with “Hold”. The positive are 36%. The firm has $78.0 highest while $47 is the lowest target. The average target $65.56 is 25.57% above the last ($52.21) price. Since February 6, 2018 according to StockzIntelligence Inc Bristol Myers has 17 analyst reports. The stock rating was upgraded by BMO Capital Markets to “Market Perform” on Friday, April 27. On Tuesday, February 6 the rating was maintained by Leerink Swann with “Buy”. On Friday, April 13 Jefferies maintained the shares of BMY in report with “Hold” rating. The company rating was maintained by Citigroup on Friday, February 16. On Tuesday, April 17 the company was maintained by Bank of America. The stock rating was maintained by BMO Capital Markets with “Underperform” on Tuesday, February 6. On Friday, April 20 the firm has “Hold” rating given by Cowen & Co. On Wednesday, February 28 the firm has “Hold” rating by DZ Bank given. In Wednesday, April 18 report BMO Capital Markets maintained the stock with “Underperform” rating. The stock rating was maintained by Guggenheim with “Buy” on Tuesday, April 17.

Bristol-Myers Squibb Company (NYSE:BMY) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: